See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Oct. 7, 2009

Gout Schizophrenia Parkinson's Disease

(HealthDay News) -- Here are the latest clinical trials, courtesy of


This study is evaluating an investigational medication for gout when used in combination with another medication.

The research site is in Dallas, Texas.

More information

Please see



This 52-week study will evaluate long-acting injectable Aripiprazole. Participants must be 18 to 60 and be diagnosed with schizophrenia.

The research site is in Chandler, Ariz.

More information

Please see


Parkinson's Disease

This study will evaluate the safety and effectiveness of an experimental treatment to reduce motor symptoms in people with advanced Parkinson's disease.

The research site is in Stanford, Calif.

More information

Please see


Copyright 2009 All rights reserved.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.